Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v16-EN | Version v15-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-02-27 | 2022-12-14 |
| Drug Identification Number | 02243676 | 02243676 |
| Brand name | RECOMBIVAX HB | RECOMBIVAX HB |
| Common or Proper name | (hepatitis B vaccine [recombinant]) | (hepatitis B vaccine [recombinant]) |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | HEPATITIS B SURFACE ANTIGEN | HEPATITIS B SURFACE ANTIGEN |
| Strength(s) | 10MCG | 10MCG |
| Dosage form(s) | SUSPENSION SOLUTION | SUSPENSION SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10MCG/1ML 1DOSE VIAL | 10MCG/1ML 1DOSE VIAL |
| ATC code | J07BC | J07BC |
| ATC description | VIRAL VACCINES | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2022-12-02 | 2022-12-02 |
| Actual start date | 2022-12-01 | 2022-12-01 |
| Estimated end date | 2023-05-12 | 2023-03-10 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Remaining doses are reserved for the public immunization program. Limited quantities available for private orders. | Remaining doses are reserved for the public immunization program. Limited quantities available for private orders. |
| Health Canada comments |